From August 18th 2026, GtoPdb will require users to register to use the website. Please see our blog post for more information.
|
Synonyms: QL-1604 | QL1604
iparomlimab is an approved drug
Compound class:
Antibody
Comment: Iparomlimab (QL1604) is a humanized monoclonal antibody against programmed cell death protein 1 (PD-1). It blocks the inhibitory PD-1/PD-L1/2 immune checkpoint.
|
| Selectivity at other protein targets | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||